Supplemental Appendix for Risk of immunogenicity during Infliximab therapy in Hidradenitis suppurativa compared with other Chronic Inflammatory Diseases: A Retrospective monocentric cohort : Supplemental Appendix

Supplemental appendix fort brief report for "Risk of immunogenicity during Infliximab therapy in Hidradenitis suppurativa compared with other Chronic Inflammatory Diseases: A Retrospective monocentric cohort" published in Journal of the. American Academy of Dermatology发表于《美国皮肤病学会杂志》的《英夫利昔单抗（Infliximab）治疗化脓性汗腺炎（Hidradenitis suppurativa）期间的免疫原性风险：与其他慢性炎症性疾病的回顾性单中心队列研究》简报的补充附录